Jersey Shore Ready ...
Health Care: Drugs
Halozyme Therapeutics Inc. (HALO: NASDAQ)
$7.39 -0.06 | -0.81%
05/24/13 - 03:56 PM ET
Portfolios with HALO
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- UserWatch
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks With Big Insider Buy...
- Contributor3 Stocks to Buy for Less Th...
- UserGFNN Stockdiagnostics 6
- ContributorStocks With Big Insider Buy...
- ContributorStocks At New 52-Week Highs...
Latest HALO Headlines from TheStreet
- 7 Stocks Under $10 Moving Higher 11.15.12 | 03:11 pm
- 5 Stocks With Big Insider Buying 08.29.12 | 11:08 am
- Halozyme Therapeutics Management Discusses Q2 2012 Results - Earnings Call Transcript 08.06.12 | 07:08 pm
- 5 Biotech Stocks Under $10 Set to Soar 07.19.12 | 11:07 am
- 5 Stocks Insiders Love Right Now 05.23.12 | 10:05 am
- Insiders Trading HALO, ULTA, HES, NVR 05.18.12 | 10:05 am
- Get These 3 Stocks for Less Than What Insiders Paid 04.30.12 | 01:04 pm
- Mattel, Endocyte, Ivanhoe Are Market Movers 04.16.12 | 05:04 pm
- Halozyme Stock Gaps Down On Today's Open (HALO) 04.16.12 | 10:04 am
- Halozyme Stock Falls On Unusually High Volume (HALO) 04.10.12 | 02:04 pm
Press Releases for HALO
- Halozyme Therapeutics Names Matt Posard To Board Of Directors - PR Newswire 03.28.13 | 04:03 pm
- Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union - PR Newswire 03.22.13 | 08:03 am
- Halozyme Therapeutics To Present At The Barclays 2013 Global Healthcare Conference - PR Newswire 03.05.13 | 04:03 pm
- Halozyme To Host Fourth Quarter And 2012 Year-End Financial Results Conference Call - PR Newswire 02.19.13 | 04:02 pm
- Halozyme Therapeutics Issues Financial Guidance For 2013 - PR Newswire 01.07.13 | 07:01 am
- Halozyme Therapeutics To Present At The 31st Annual J.P. Morgan Healthcare Conference - PR Newswire 01.03.13 | 04:01 pm
- Halozyme Therapeutics And Pfizer Enter Into A Collaboration To Develop And Commercialize Subcutaneous Biologics Using Recombinant Human Hyaluronidase - PR Newswire 12.21.12 | 07:12 am
- ViroPharma And Halozyme Therapeutics Announce Initiation Of Phase 2b Dose Ranging Combination Study For Subcutaneous Administration Of Cinryze® (C1 Esterase Inhibitor [human]) With Hyaluronidase (rHuPH20) - PR Newswire 12.19.12 | 07:12 am
- Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera - PR Newswire 12.08.12 | 09:12 am
- Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference - PR Newswire 11.06.12 | 04:11 pm
Partner Headlines for HALO
- Halozyme Therapeutics Earnings: Here’s Why Investors are Ambivalent Now - Wall St. Cheat Sheet 05.08.13 | 07:05 am
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
- Market Wrap for Friday, March 22: Stocks Rise on Hopes of Bailout Deal for Cyprus - Benzinga 03.22.13 | 04:03 pm
- Pertaining to Relief for ViroPharma - Analyst Blog - NASDAQ 09.25.12 | 07:09 pm
- ViroPharma Misses Zacks Estimates - Analyst Blog - Zacks 08.10.12 | 09:08 am
- VPHM Manufacturing Process Approved - Analyst Blog - Zacks 08.07.12 | 07:08 pm
- Bad News for ViroPharma - Analyst Blog - Zacks 08.03.12 | 06:08 pm
- After Hours Most Active for Aug 1, 2012 : SAN, GMCR, NOK, FSLR, BBVA, SBUX, BAC, JNJ, LEN, HALO, QQQ, SPLS - NASDAQ 08.01.12 | 08:08 pm
- Rituxan And Its Biosimilar Competitors - Seeking Alpha 07.30.12 | 09:07 am
- Healthcare Biz Recap: GlaxoSmithKline BUYS Drugs, Sanofi Gains Traction - Wall St. Cheat Sheet 06.12.12 | 06:06 am
